InvestorsHub Logo
Followers 90
Posts 11287
Boards Moderated 0
Alias Born 06/06/2014

Re: Milarepa post# 2515

Sunday, 04/02/2017 10:00:04 PM

Sunday, April 02, 2017 10:00:04 PM

Post# of 3063
The Joint Report is interesting reading. I disagree a bit with the RoA characterization of Chromadex's statement being "sharp". It was poorly written (when did lawyers lose their professional writing skills?), but it is concise and pointed and the complaints are plain to see. Elysium's statement shows legitimate complaints too. Chromadex has some explaining to do, but Elysium has its back to the wall thanks to Chromadex's NR intellectual property.

I suspect an eventual settlement, as RoA says. It is in both parties interests, and likely will result in payment of the Chromadex bill and a revised sales agreement.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDXC News